Intended for healthcare professionals

Letters Industry-funded medical education

Author’s reply to McMahon

BMJ 2021; 374 doi: https://doi.org/10.1136/bmj.n1816 (Published 23 July 2021) Cite this as: BMJ 2021;374:n1816
  1. Adriane Fugh-Berman, professor
  1. Georgetown University Medical Center, Washington, DC, USA
  1. ajf29{at}georgetown.edu

It’s simply not true that the Accreditation Council for Continuing Medical Education (ACCME) rules “safeguard continuing medical education (CME) from commercial bias,”12 a statement that McMahon references to an unpublished white paper commissioned by ACCME.3 We have documented clear promotional messaging that supports specific drugs in accredited CME activities on hypoactive sexual desire disorder,4 breakthrough pain,5 and binge eating disorder.6 Every other study examining commercial bias or changes in prescribing behaviour related to industry-funded CME has found bias because, well, …

View Full Text

Log in

Log in through your institution

Subscribe

* For online subscription